Clinical significance of cerebrovascular complications in patients with acute infective endocarditis: a retrospective analysis of a 12-year single-center experience
© Lee et al.; licensee BioMed Central Ltd. 2014
Received: 1 July 2013
Accepted: 11 February 2014
Published: 15 February 2014
Cerebrovascular complications (CVCs) frequently occur in patients with acute infective endocarditis (IE). The aim of this study is to describe the clinical findings of CVCs and to evaluate the impact of CVCs on long-term mortality in patients with IE.
We retrospectively analyzed 144 patients who fulfilled the modified Duke’s criteria for definite left-sided IE. CVCs were classified into minor (silent cerebral embolism, TIA and stroke with an initial modified Rankin scale ≤ 2) or major (an initial modified Rankin scale ≥ 3) CVCs. Cox proportional hazards model was used for mortality analysis. Hazard ratio (HR) and 95% confidence interval (CI) were obtained.
The mean age of the 144 patients (96 males and 48 females) was 49.1 years (range 6-85 years). A CVC was found in 37 (25.7%) patients. Of these, 25 were treated with surgical therapy. The patients who underwent early surgery within 2 weeks after stroke had a statistical trend toward a higher risk of postoperative brain hemorrhage (50% versus 4.8%, P = 0.057 by Fisher exact test). The minor CVC group had a similar risk of death as the no-CVC group (P = 0.803; HR 0.856; CI 0.253-2.894), whereas the major CVC group had a higher mortality (P = 0.013; HR 2.865; CI 1.254-6.548) than the no-CVC group. In the multivariate analysis, major CVC (P = 0.002; HR 3.893; CI 1.649-9.194) was a significant predictor of mortality in IE patients, together with advanced age (P = 0.005; HR 3.138; CI 1.421-6.930) and prosthetic valve IE (P = 0.008; HR 2.819; CI 1.315-6.044).
IE can give rise to various forms of CVC, most frequently, acute ischemic brain lesions. In our study, major CVC was associated with high risk of mortality although total CVC was not significantly related to the risk of death in patients with IE.
KeywordsInfective endocarditis Cerebrovascular complication Stroke
Cerebrovascular complications (CVCs) frequently occur in patients who are in the active stage of infective endocarditis (IE), and result from cerebral septic embolization of an endocardial vegetation. They include stroke, transient ischemic attack (TIA) and silent cerebral embolism (SCE).
A CVC is generally accepted as a predictor of poor prognosis with an increased mortality in patients with IE [1–3]. Especially, several studies have recently reported that the mortality in IE patients depends on type or severity of IE-related CVC [4, 5].
In this study, we attempted to (1) describe the incidence, lesion type and neurologic outcome of CVCs, (2) identify the variables determining the occurrence of CVCs and (3) elucidate the impact of types of CVCs on long-term mortality in patients with IE.
Using the endocarditis registry of Sejong Cardiovascular Center, the authors of this study ascertained the names and registry numbers of 282 consecutive patients with suspected IE, who were admitted to the Cardiovascular Center at Sejong General Hospital between January 2000 and September 2012. We then retrospectively reviewed their medical records. From these 282 patients, 104 patients with right-sided IE, 27 with possible left-sided IE, and 7 with incomplete study were excluded. Patients with both left- and right-sided IE were classified into the left-sided group. Finally, we analyzed 144 patients who fulfilled the modified Duke’s criteria  for definite left-sided IE, and investigated detailed clinical information including medical history (age, sex, hypertension, diabetes mellitus, Charlson comorbidity index , atrial fibrillation, current smoking status, congestive heart failure (CHF) and history of IE), operation records, computed tomography (CT), magnetic resonance imaging (MRI), echocardiography and clinical outcome including mortality. The follow-up data were obtained from outpatient medical records. The study protocol was reviewed and approved by the Institutional Review Board of Sejong General Hospital. In addition, we had consent from patients or their legal guardians to publish clinical details.
Transthoracic and transesophageal echocardiography were performed in all cases. Echocardiographic data included IE-related valve regurgitation, vegetation length, mobility and location. The vegetation length was measured in various planes during the first echocardiography and follow-up studies. It was determined whether the maximal vegetation length was > 1 cm.
Diagnosis of a CVC was based on clinical findings, CT or MRI. CVCs included stroke (ischemic or hemorrhagic), TIA, and SCE. An ischemic stroke was defined as a focal neurologic deficit of an abrupt onset lasting > 24 hours with an evidence of new lesions on brain imaging, whereas TIA was defined as a focal neurologic symptom lasting < 24 hours with or without brain lesions. Hemorrhagic stroke was defined as a neurologic symptom with the presence of intracranial bleeding on CT or MRI, and included primary intracerebral hemorrhage (ICH), hemorrhagic infarct (HI) and subarachnoid hemorrhage (SAH). A new asymptomatic brain lesion with high signal intensity on diffusion MRI was considered as SCE.
CVCs were classified into minor or major CVCs. A minor CVC was diagnosed when the initial neurologic signs were absent, transient or mild. This category included SCEs, TIAs and strokes with an initial modified Rankin scale (mRS) ≤ 2. A major CVC was defined as a stroke that initially caused a moderate to severe disability (mRS ≥ 3). In addition, cerebral infarct combined with intracranial hemorrhage or one type of CVCs with additional neurologic complications (seizure, meningitis or mycotic aneurysm) was considered as a complicated stroke.
The topography of brain lesions was determined using the commonly accepted arterial supply templates for the territorial and border zone areas, as described previously [8–10]. Multiple infarcts were defined as more than two lesions that were topographically distinct (separated in space or discrete on contiguous slices) . An uninterrupted lesion visible in contiguous territories was considered a single lesion.
Statistical analyses were performed with SPSS software, version 18.0 (SPSS Inc., Chicago, IL). Independent t-test or Chi-square test (or Fisher exact test) was used for comparing the different groups. Multivariate logistic regression analysis was performed to determine the independent predictors for IE-related CVCs. Odds ratio (OR) and 95% confidence interval (CI) were obtained. Besides, the Kaplan-Meier survival curves were computed according to the type of CVC, and compared using the log-rank test. Cox proportional hazards model was used to perform univariate and multivariate analyses for long-term mortality. Unadjusted and adjusted hazards ratio (HR) and CI were obtained. P-values < 0.05 were considered statistically significant.
General characteristics of the study population
The mean age of 144 patients (96 males and 48 females) included in this study was 49.1 years (range 6-85 years) at admission. There were 134 patients with only left-sided IE and 10 with both-sided IE.
General characteristics in patients with and without cerebrovascular complications related to infective endocarditis: mean ± SD, n (%)
CVC (-) N = 107
CVC (+) N = 37
49.5 ± 18.1
48.0 ± 17.1
History of IE
History of CHF
Comorbidity index >2
Initial C-reactive protein level, mg/dL
7.4 ± 7.3
8.9 ± 6.3
Diagnostic delay, days
32.8 ± 35.3
29.9 ± 33.3
Mitral valve IE
Aortic valve IE
Dual valve IE
Warfarin use at admission
Coagulase negative staphylococci
Negative blood cultures
Vegetation size >1 cm
IE-related valve regurgitation
In addition, 31 peripheral embolic events were identified, involving the spleen in 10 patients (6.9%), kidneys in 7 patients (4.9%), lower limbs in 7 patients (4.9%), heart in 4 patients (2.8%; left anterior descending artery in 3 and right coronary artery in 1) and lungs in 3 patients (2.1%) with both-sided IE.
When compared with the no-CVC group, the CVC group had a significantly higher prevalence of staphylococcus (S.) aureus infection, large (> 1 cm) and mobile vegetation (P < 0.05); and showed a statistical trend toward a higher frequency of smoking, dialysis, mitral valve involvement, no surgery and in-hospital mortality (P < 0.2). However, there was no significant difference in age, gender, hypertension, diabetes mellitus, atrial fibrillation, history of CHF, comorbidity, C-reactive protein level at admission, period from the initial symptom to diagnosis and warfarin use at admission between the two groups.
Logistic regression analysis (using the variables of mitral valve IE, smoking, S. aureus and mobile vegetation) demonstrated that S. aureus infection (P = 0.047; OR 3.012; CI 1.013-8.962) and mobile vegetation (P = 0.001; OR 4.768; CI 1.952-11.647) were independent predictors of CVC in patients with left-sided IE.
One hundred and eleven of the 144 patients (77.1%) underwent surgical therapy (53 biologic valves, 36 mechanical valves, 16 valve repairs and 6 aortic homograft valves). When compared with the surgery group, the no-surgery group had a significantly higher proportion of the elderly aged 65 years and older (39.4% versus 14.4%; P = 0.002) and high-comorbidity (index > 2) patients (36.4% versus 17.1%; P = 0.018).
Characteristics of the patients with a CVC
Prevalence of neurologic complications in 144 patients with acute infective endocarditis: n (%)
Total cerebrovascular complications
ICH + ischemic stroke
SAH + ischemic stroke
Imaging characteristics of 33 patients with ischemic brain lesions related to infective endocarditis: n (%)
Of the 37 patients with a CVC, 25 were treated with surgical therapy. The mean duration from brain imaging to surgery was 42 days (range 3-143 days). Only 3 of 25 patients treated with surgery expired, while 7 out of 12 patients without surgery died during hospitalization (12.0% versus 58.3%, P = 0.006). Of the 25 patients treated with surgery, 4 underwent surgical treatment within 2 weeks after the diagnosis of a minor ischemic CVC (early surgery group), whereas the other 21 underwent surgical treatment after more than 2 weeks (delayed surgery group). Two of 4 patients who underwent early surgery had postoperative intracranial bleeding (left frontal SAH and intraventricular hemorrhage, respectively), whereas only one of 21 patients who underwent delayed surgery developed SAH and subdural hematoma in the right frontotemporal region postoperatively (50% versus 4.8%, P = 0.057). Among the 4 patients who underwent early surgery, the patient who developed intraventricular hemorrhage died from hydrocephalus and brain herniation, while 2 of 21 patients who underwent delayed surgery expired due to postoperative brain complications (the patient mentioned earlier) and septic shock, respectively (25.0% versus 9.5%, P = 0.422). Thus, the early surgery group had a statistical trend toward a higher risk of postoperative brain complications.
Influence of a CVC on the outcome in patients with IE
The median follow-up period was 51.9 months (range 2 - 149 months). Of the 144 patients with IE, 28 died during hospitalization. The most common cause of in-hospital death was sepsis with multiple organ failure (18 cases, 64.3%), followed by postoperative ICH (3 cases, 10.7%), cerebral infarct progression (2 cases, 7.1%), preoperative ICH (2 cases, 7.1%), sudden cardiac arrest (2 cases, 7.1%) and postoperative bleeding complication (1 case, 3.6%). In addition, two patients expired due to pulmonary embolism and sudden cardiac arrest, respectively after hospital discharge. Of the 144 patients, 4 without a CVC and 2 with a minor CVC (4.2%) were lost during the follow-up period. These patients were censored at their last clinic visit.
Of the 20 patients with a minor CVC, 17 (85.0%) had no disability (mRS 0 or 1) and the other 3 (15.0%) were dead at 6 months. In contrast, only 2 (11.8%) of the 17 patients with a major CVC had no disability (mRS 0 or 1). In the remaining patients (88.2%), the outcome was disability or death at 6 months; 8 patients (47.1%) had a significant disability (mRS 2 or 3 in 7 patients and mRS 5 in 1 patient) and the other 7 (41.2%) were dead at 6 months.
Of the 37 patients with a CVC, 16 patients had a complicated stroke, which included 11 cases of ischemic stroke combined with hemorrhage, 1 case of ICH related to mycotic aneurysm, 1 case of ischemic stroke with meningitis, 2 cases of seizures associated with ischemic stroke and 1 case of ischemic stroke with ICH/seizure. There was no significant difference in mortality between the no-CVC group, uncomplicated stroke group and complicated stroke group (Figure 2B, P = 0.142). In addition, the vascular territory (the involvement of MCA territory) was not related to the risk of death in patients with IE (Figure 2C, P = 0.210).
Results of the univariate and multivariate Cox proportional hazard models for mortality
Multivariate (model 1)
Multivariate (model 2)
History of CHF
Comorbidity index >2
Mitral valve IE
Aortic valve IE
Dual valve IE
In addition, two levels of multivariate analysis were performed to evaluate the impact of a major CVC on mortality. In the model 1 where only the age was adjusted, major CVC (P = 0.002; HR 3.786; CI 1.635-8.771) was significantly associated with high risk of death in patients with IE. In the model 2, prosthetic valve IE was added as a variable in the multivariate analysis. Comorbidity and S. aureus were excluded despite their statistical significance in the univariate analysis because they were closely related to major CVC (P = 0.011 and 0.012 respectively by Chi-square test) thus having a potential to behave as redundant variables (multicollinearity). In this analysis, major CVC (P = 0.002; HR 3.893; CI 1.649-9.194) remained a significant predictor of mortality in IE patients, together with advanced age (P = 0.005; HR 3.138; CI 1.421-6.930) and prosthetic valve IE (P = 0.008; HR 2.819; CI 1.315-6.044).
A CVC was observed in 25.7% of the patients with IE, which is within the range of 10 to 80% that has been reported in previous studies [2, 3, 5, 13–16]. A wide variation in the prevalence among studies may be due to the failure to detect mild or transient neurologic signs in critically ill patients leading to an underestimation of CVC, especially in retrospective studies that used chart reviews. In contrast, the rate of IE-related CVC can be increased more in patients with S. aureus infection and severe form of the disease necessitating intensive care unit admission [2, 3]. Additionally, more frequent scanning of brain, especially using diffusion-weighted MRI, enhances the detection rate of brain lesions in IE patients. Several prospective studies with a higher frequency of brain imaging showed that the incidence of CVC could reach 65-80% although many patients were asymptomatic [15, 16].
In many previous studies, S. aureus infection has been found to be associated with a high rate of stroke and mortality in IE patients [3, 17, 18]. Our results also showed that S. aureus infection has a significant relationship with the occurrence of a CVC and death on the univariate analysis. In addition, multivariate analysis performed in this study demonstrated that S. aureus infection together with mobile vegetation independently predicted CVC in IE patients.
The most common type of neurologic complication related to IE was acute ischemic stroke (30 cases, 20.8%), followed by hemorrhagic stroke (16 cases, 11.1%), seizures (3 cases, 2.1%) and TIA (2 cases, 1.4%). SCE, meningitis and mycotic aneurysm were found in only l patient (0.7%), each. Of these, SCE and meningitis had a lower incidence rate (0.7%) in our study than that in previous recent studies, in which SCE was found in 4-30% of patients with IE [3, 5, 16] and meningitis was found in 3-25% of patients with IE [1, 4, 19]. This could be explained partly by the non-routine use of brain imaging in this study. For example, most of the brain scans seem to have been done only when the patients had a clinical symptom suggesting brain complications. In addition, headache, if mild, may not have been investigated for meningitis in patients with serious heart conditions.
Acute ischemic lesions in IE patients are mostly multiple, and mainly located in the MCA territory corresponding with the cardioembolic stroke subtype. In addition, various patterns of lesions including single, territorial, disseminated punctate, and disseminated small and large lesions were seen. These results of this study coincide with those of a previous study , which showed that IE-related strokes had all the patterns of lesions from pattern 1 to 4, whereas strokes associated with adenocarcinoma-related, nonbacterial thrombotic endocarditis (NBTE) had only pattern 4 lesions. This difference in lesion patterns between two diseases can be explained by the presumption that vegetation in IE causes an inflammatory reaction within itself, and hence the vegetation can conglomerate more firmly and will not fragment more easily than that in NBTE.
During cardiac surgery, neurological deterioration can occur in patients with IE and CVC. This is presumed to be attributable to intralesional hemorrhage related to heparinization and extension of infarcted area resulting from hypotension during cardiopulmonary bypass . Previous studies have shown that the risk of neurologic deterioration related to cardiac surgery declines over the first month [21, 22]. Therefore, the recent guideline of the Society of Thoracic Surgeons recommends delaying the surgery for at least 4 weeks from the stroke onset in IE patients with a major ischemic stroke or any intracranial hemorrhage, and permits a shorter delay of 2-4 weeks in the patients with a small brain infarct and severe cardiac conditions necessitating urgent surgery . Our study also showed that early surgery within 2 weeks seemed to increase the probability of neurological deterioration, although this result did not reach statistical significance due to the small sample size.
However, several recent studies reported that the risk of neurological deterioration due to early cardiac surgery may be lower than that assumed previously, except in patients with intracranial bleeding [23, 24]. They emphasized that early cardiac surgery is not contraindicated after ischemic stroke and can be performed without delay when there are indications for surgery. Thus, the optimal timing of cardiac surgery in IE patients with a CVC is controversial, and large-scale controlled studies are required in the future. Accordingly, the decision regarding the timing of surgery should be individualized, and based on a multidisciplinary approach to optimize the combined management of the cardiac and cerebral diseases.
In this study, total CVC was not significantly related to higher mortality in IE patients. Instead, the risk of death differed according to the severity of the initial neurologic symptom of CVC. Patients with a minor CVC had a better prognosis than patients with a major CVC, and there was no difference in mortality between the minor and no CVC groups. In contrast, major CVC proved to be a significant determinant of mortality in IE patients. This result is similar to that of a previous study, which demonstrated that high risk of death in IE patients was related to clinically overt stroke, but not to SCE or TIA .
Previous studies have discussed the association between CVC and long-term outcome in patients with IE [2–5]. Some previous studies showed similar results to those in our study, thereby indicating that total CVC was not significantly associated with the risk of death in IE patients . However, other studies reported that neurologic complication was an independent predictor of mortality in IE patients [2, 3]. This might be attributable to the difference in the study population, management protocol like the timing of cardiac surgery or statistical variables between the studies.
The present study has several limitations. First of all, the main limitation of this study may be the small sample size based on a single-center experience resulting in the attenuation of statistical power in the mortality analysis. Second, patients were not managed according to a standardized protocol, and the data were collected retrospectively. Thus, an arbitrary decision about patient management could have influenced the results of this study. For example, brain imaging was performed in only about half of the study patients based on the decision of the attending physician in each situation. Particularly, the critically ill patients did not seem to undergo MRI because it could put them at a greater risk. Consequently, the rate of asymptomatic brain infarct could have been underestimated in comparison with that in the results of several previous studies.
IE can give rise to various forms of CVC, most frequently, acute ischemic brain lesions. In our study, major CVC (initial mRS ≥ 3) was associated with high risk of mortality although total CVC was not significantly related to the risk of death in patients with IE.
The authors thank the following colleagues for their contributions to data acquisition in the study: Drs Young-Moo Ro, Suk-Keun Hong, Rak-Kyeong Choi, Cheol-Woong Yu and Jin-Sik Park, Department of Cardiology, Sejong General Hospital, Bucheon, South Korea.
- Sonneville R, Mourvillier B, Bouadma L, Wolff M: Management of neurological complications of infective endocarditis in ICU patients. Ann Intensive Care. 2011, 1: 10-10.1186/2110-5820-1-10.View ArticlePubMedPubMed CentralGoogle Scholar
- Mourvillier B, Trouillet JL, Timsit JF, Baudot J, Chastre J, Régnier B, Gibert C, Wolff M: Infective endocarditis in the intensive care unit: clinical spectrum and prognostic factors in 228 consecutive patients. Intensive Care Med. 2004, 30: 2046-2052. 10.1007/s00134-004-2436-9.View ArticlePubMedGoogle Scholar
- Sonneville R, Mirabel M, Hajage D, Tubach F, Vignon P, Perez P, Lavoué S, Kouatchet A, Pajot O, Mekontso Dessap A, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Tabah A, Trouillet JL, Wolff M, ENDOcardite en REAnimation Study Group: Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDOcardite en REAnimation prospective multicenter study. Crit Care Med. 2011, 39: 1474-1481. 10.1097/CCM.0b013e3182120b41.View ArticlePubMedGoogle Scholar
- Ruttmann E, Willeit J, Ulmer H, Chevtchik O, Höfer D, Poewe W, Laufer G, Müller LC: Neurological outcome of septic cardioembolic stroke after infective endocarditis. Stroke. 2006, 37: 2094-2099. 10.1161/01.STR.0000229894.28591.3f.View ArticlePubMedGoogle Scholar
- Thuny F, Avierinos JF, Tribouilloy C, Giorgi R, Casalta JP, Milandre L, Brahim A, Nadji G, Riberi A, Collart F, Renard S, Raoult D, Habib G: Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study. Eur Heart J. 2007, 28: 1155-1161. 10.1093/eurheartj/ehm005.View ArticlePubMedGoogle Scholar
- Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Ryan T, Bashore T, Corey GR: Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000, 30: 633-638. 10.1086/313753.View ArticlePubMedGoogle Scholar
- Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40: 373-383. 10.1016/0021-9681(87)90171-8.View ArticlePubMedGoogle Scholar
- Tatu L, Moulin T, Bogousslavsky J, Duvernoy H: Arterial territories of the human brain: brainstem and cerebellum. Neurology. 1996, 47: 1125-1135. 10.1212/WNL.47.5.1125.View ArticlePubMedGoogle Scholar
- Tatu L, Moulin T, Bogousslavsky J, Duvernoy H: Arterial territories of the human brain: cerebral hemisphere. Neurology. 1998, 50: 1699-1708. 10.1212/WNL.50.6.1699.View ArticlePubMedGoogle Scholar
- Ringelstein EB, Stogbauer F: Border zone infarcts. Stroke Syndromes. Edited by: Bogousslavsky J, Caplan L. 2001, New York: Cambridge University Press, 564-582. 2View ArticleGoogle Scholar
- Wong KS, Gao S, Chan YL, Hansberg T, Lam WW, Droste DW, Kay R, Ringelstein EB: Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol. 2002, 52: 74-81. 10.1002/ana.10250.View ArticlePubMedGoogle Scholar
- Singhal AB, Topcuoglu MA, Buonanno FS: Acute ischemic stroke patterns in infective and nonbacterial thrombotic endocarditis: a diffusion-weighted magnetic resonance imaging study. Stroke. 2002, 33: 1267-1273. 10.1161/01.STR.0000015029.91577.36.View ArticlePubMedGoogle Scholar
- Anderson DJ, Goldstein LB, Wilkinson WE, Corey GR, Cabell CH, Sanders LL, Sexton DJ: Stroke location, characterization, severity, and outcome in mitral vs aortic valve endocarditis. Neurology. 2003, 61: 1341-1346. 10.1212/01.WNL.0000094359.47929.E4.View ArticlePubMedGoogle Scholar
- Okazaki S, Yoshioka D, Sakaguchi M, Sawa Y, Mochizuki H, Kitagawa K: Acute ischemic brain lesions in infective endocarditis: incidence, related factors, and postoperative outcome. Cerebrovasc Dis. 2013, 35: 155-162. 10.1159/000346101.View ArticlePubMedGoogle Scholar
- Duval X, Iung B, Klein I, Brochet E, Thabut G, Arnoult F, Lepage L, Laissy JP, Wolff M, Leport C, IMAGE (Resonance Magnetic Imaging at the Acute Phase of Endocarditis) Study Group: Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010, 152: 497-504. 10.7326/0003-4819-152-8-201004200-00006.View ArticlePubMedGoogle Scholar
- Snygg-Martin U, Gustafsson L, Rosengren L, Alsiö A, Ackerholm P, Andersson R, Olaison L: Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage markers. Clin Infect Dis. 2008, 47: 23-30. 10.1086/588663.View ArticlePubMedGoogle Scholar
- Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators: Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009, 169: 463-473. 10.1001/archinternmed.2008.603.View ArticlePubMedPubMed CentralGoogle Scholar
- Fowler VG, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, ICE Investigators: Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005, 293: 3012-3021. 10.1001/jama.293.24.3012.View ArticlePubMedGoogle Scholar
- Lepur D, Barsić B: Incidence of neurological complications in patients with native-valve infective endocarditis and cerebral microembolism: an open cohort study. Scand J Infect Dis. 2009, 41: 708-713. 10.1080/00365540903146995.View ArticlePubMedGoogle Scholar
- Derex L, Bonnefoy E, Delahaye F: Impact of stroke on therapeutic decision making in infective endocarditis. J Neurol. 2010, 257: 315-321. 10.1007/s00415-009-5364-3.View ArticlePubMedGoogle Scholar
- Angstwurm K, Borges AC, Halle E, Schielke E, Einhäupl KM, Weber JR: Timing the valve replacement in infective endocarditis involving the brain. J Neurol. 2004, 251: 1220-1226. 10.1007/s00415-004-0517-x.View ArticlePubMedGoogle Scholar
- Byrne JG, Rezai K, Sanchez JA, Bernstein RA, Okum E, Leacche M, Balaguer JM, Prabhakaran S, Bridges CR, Higgins RS: Surgical management of endocarditis: the society of thoracic surgeons clinical practice guideline. Ann Thorac Surg. 2011, 91: 2012-2019. 10.1016/j.athoracsur.2011.01.106.View ArticlePubMedGoogle Scholar
- Barsic B, Dickerman S, Krajinovic V, Pappas P, Altclas J, Carosi G, Casabé JH, Chu VH, Delahaye F, Edathodu J, Fortes CQ, Olaison L, Pangercic A, Patel M, Rudez I, Tamin SS, Vincelj J, Bayer AS, Wang A, International Collaboration on Endocarditis–Prospective Cohort Study Investigators: Influence of the timing of cardiac surgery on the outcome of patients with infective endocarditis and stroke. Clin Infect Dis. 2013, 56: 209-217. 10.1093/cid/cis878.View ArticlePubMedGoogle Scholar
- Yoshioka D, Sakaguchi T, Yamauchi T, Okazaki S, Miyagawa S, Nishi H, Yoshikawa Y, Fukushima S, Saito S, Sawa Y: Impact of early surgical treatment on postoperative neurologic outcome for active infective endocarditis complicated by cerebral infarction. Ann Thorac Surg. 2012, 94: 489-495. 10.1016/j.athoracsur.2012.04.027.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/14/30/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.